Copyright
©The Author(s) 2002.
World J Gastroenterol. Dec 15, 2002; 8(6): 1053-1058
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1053
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.1053
Figure 5 Effects of tachyplesin on the levels of α-FP, PCNA, p21WAF1/CIP1, c-myc proteins in SMMC-7721 cells ( × 536).
A: The high level of α-FP in SMMC-7721 cells detected by immunocytochemistry; B: The level of α-FP in the tachyplesin-treated SMMC-7721 cells is decreased; C: The high level of PCNA in SMMC-7721 cells; D: The level of PCNA in the tachyplesin-treated SMMC-7721 cells is decreased; E: The low level of p21WAF1/CIP1 in SMMC-7721 cells; F: The level of p21WAF1/CIP1 in the tachyplesin-treated SMMC-7721 cells is increased; G: The high level of c-myc in SMMC-7721 cells; H: The level of c-myc in the tachyplesin-treated SMMC-7721 cells is decreased.
- Citation: Ouyang GL, Li QF, Peng XX, Liu QR, Hong SG. Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells. World J Gastroenterol 2002; 8(6): 1053-1058
- URL: https://www.wjgnet.com/1007-9327/full/v8/i6/1053.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i6.1053